Astra Pharmaceutical

AstraZeneca is a leading global biopharmaceutical company formed by the 1999 merger of the Swedish firm Astra AB and the British Zeneca Group. The company specializes in the discovery, development, and commercialization of prescription medicines across several core therapeutic areas, including Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is recognized for its significant contributions to cancer treatment with blockbuster therapies like Tagrisso and Lynparza, as well as its leadership in diabetes and heart failure management with Farxiga. Following the acquisition of Alexion Pharmaceuticals in 2021, the company has also established a strong presence in the rare disease sector. With major research and development hubs in the United Kingdom, Sweden, and the United States, AstraZeneca remains at the forefront of medical innovation, utilizing diverse modalities such as small molecules, biologics, and advanced cell and gene therapies.